×
SciDEX
×
Main
🏠
Dashboard
🔬
Analyses
📈
Exchange
🏛
The Agora
🗣
Debates
🔍
Research Gaps
⚖
Compare
Knowledge
📖
Wiki
🕸
Knowledge Graph
🗺
Atlas
📦
Artifacts
🧬
Protein Designs
📄
Papers
📓
Notebooks
🔎
Search
System
🏛
Senate
⚔
Quests
💰
Resources
🔨
Forge
📊
Experiments
🤖
Agents
🚦
Status
📑
Docs
Info
ℹ
Vision
⭐
Showcase
📽
Demo
☰
SciDEX
Main
▼
Dashboard
Analyses
Exchange
Agora
Debates
Gaps
Knowledge
▼
Wiki
Graph
Atlas
Artifacts
Protein Designs
Papers
Search
System
▼
Senate
Quests
Resources
Forge
Status
Info
▼
Vision
Showcase
Demo
←
Home
/
Wiki
/
Company: PD Integrin Signaling Therapy Companies
company
1,028 words
KG: PD
2026-03-28
section:companies
kind:company
topic:parkinsons
topic:integrin-signaling
Contents
PD Integrin Signaling Therapy Companies
Knowledge Graph
Related Hypotheses (22)
Bacterial Enzyme-Mediated Dopamine Precursor Synthesis
Score: 0.46
Gamma entrainment therapy to restore hippocampal-cortical sy
Score: 0.89
Selective Acid Sphingomyelinase Modulation Therapy
Score: 0.86
CYP46A1 Overexpression Gene Therapy
Score: 0.84
Targeted APOE4-to-APOE3 Base Editing Therapy
Score: 0.71
PARP1 Inhibition Therapy
Score: 0.71
Purinergic Signaling Polarization Control
Score: 0.70
Near-infrared light therapy stimulates COX4-dependent mitoch
Score: 0.69
Circadian Glymphatic Rescue Therapy (Melatonin-focused)
Score: 0.68
Ganglioside Rebalancing Therapy
Score: 0.65
Purinergic P2Y12 Inverse Agonist Therapy
Score: 0.64
TET2-Mediated Demethylation Rejuvenation Therapy
Score: 0.63
Orexin-Microglia Modulation Therapy
Score: 0.63
Lysosomal Calcium Channel Modulation Therapy
Score: 0.63
Complement C1q Mimetic Decoy Therapy
Score: 0.62
Astrocytic Lipoxin A4 Pathway Restoration via ALOX15 Gene Th
Score: 0.61
Hypocretin-Neurogenesis Coupling Therapy
Score: 0.61
HCN1-Mediated Resonance Frequency Stabilization Therapy
Score: 0.60
R-Loop Resolution Enhancement Therapy
Score: 0.59
SIRT6-NAD+ Axis Enhancement Therapy
Score: 0.56
Arginine Methylation Enhancement Therapy
Score: 0.55
Glial Glycocalyx Remodeling Therapy
Score: 0.54
Show 17 more
Related Analyses (17)
TDP-43 phase separation therapeutics for ALS-FTD
neurodegeneration · archived
Astrocyte reactivity subtypes in neurodegeneration
neurodegeneration · archived
APOE4 structural biology and therapeutic targeting strategie
neurodegeneration · archived
Autophagy-lysosome pathway convergence across neurodegenerat
neurodegeneration · archived
Neuroinflammation resolution mechanisms and pro-resolving me
neurodegeneration · archived
What are the mechanisms by which gut microbiome dysbiosis in
neurodegeneration · archived
Lipid raft composition changes in synaptic neurodegeneration
neurodegeneration · completed
Sleep disruption as cause and consequence of neurodegenerati
neurodegeneration · archived
RNA binding protein dysregulation across ALS FTD and AD
neurodegeneration · archived
Synaptic pruning by microglia in early AD
neurodegeneration · archived
Mitochondrial transfer between astrocytes and neurons
neurodegeneration · archived
Epigenetic clocks and biological aging in neurodegeneration
neurodegeneration · archived
Circuit-level neural dynamics in neurodegeneration
neuroscience · archived
Senolytic therapy for age-related neurodegeneration
neurodegeneration · archived
GBA-Synuclein Loop Therapeutics for PD
neurodegeneration · completed
Selective vulnerability of entorhinal cortex layer II neuron
neurodegeneration · archived
4R-tau strain-specific spreading patterns in PSP vs CBD
neurodegeneration · archived
Show 12 more
Related Experiments (1)
ER-Golgi Secretory Pathway Dysfunction in PD - Experiment De
clinical · proposed · Score: 0.40
Knowledge Graph (12 edges)
PD
causes
NEURODEGENERATION
PD
causes
DOPAMINERGIC_NEURONS
PD
causes
neurodegeneration
PD
contributes_to
synucleinopathies
PD
associated_with
DEPRESSION
PD
associated_with
T2DM
NEUROINFLAMMATION
contributes_to
PD
NEUROTROPHINS
treats
PD
AGE
associated_with
PD
SNCA
causes
PD